Dr. Rachel Kapelow
What this data tells you about Dr. Kapelow
Dr. Rachel Kapelow is a rheumatology specialist in Delray Beach, FL, with 10 years of NPI registration. Based on federal Medicare data, Dr. Kapelow performed 176,782 Medicare services across 7,210 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kapelow received a total of $3,482 from 19 pharmaceutical and/or device companies across 201 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kapelow is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Florida License Status
FL DOH · MQA| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 149102 | Clear | January 31, 2027 | — |
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) | 78,200 | $4 | $21 |
| Denosumab injection (Prolia/Xgeva) | 17,640 | $18 | $53 |
| Tocilizumab injection (Actemra) | 17,360 | $5 | $14 |
| Romosozumab injection (Evenity) for osteoporosis | 15,333 | $8 | $24 |
| Abatacept infusion (Orencia) | 13,150 | $34 | $134 |
| Steroid injection (triamcinolone) | 11,192 | $1 | $4 |
| Golimumab infusion (Simponi Aria) | 10,600 | $10 | $59 |
| Office visit, established patient (30-39 min) | 2,376 | $98 | $338 |
| Extended-release steroid injection (Zilretta) | 1,636 | $13 | $48 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 1,037 | $58 | $232 |
| Ultrasonic guidance for needle placement | 797 | $47 | $380 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 700 | $87 | $355 |
| Injection into tendon or ligament | 695 | $46 | $222 |
| Methotrexate sodium, 5 mg | 681 | $0 | $1 |
| Betamethasone steroid injection | 520 | $5 | $18 |
| Blood draw (venipuncture) | 488 | $8 | $21 |
| Limited ultrasound scan of joint or other extremity structure except blood vessels | 434 | $34 | $147 |
| Administration of chemotherapy into vein, 1 hour or less | 321 | $105 | $479 |
| Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | 306 | $50 | $200 |
| X-ray of hand, minimum of 3 views | 279 | $29 | $96 |
| X-ray of lower and sacral spine, 2-3 views | 238 | $32 | $105 |
| New patient office visit (45-59 min) | 237 | $119 | $533 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 219 | $57 | $380 |
| Complete ultrasound scan of joint | 211 | $43 | $242 |
| Shoulder X-ray, 2+ views | 172 | $27 | $91 |
| Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) | 153 | $50 | $166 |
| Office visit, established patient (20-29 min) | 144 | $67 | $238 |
| X-ray of pelvis, 1-2 views | 138 | $23 | $73 |
| Drug injection, under skin or into muscle | 121 | $11 | $73 |
| Foot X-ray, 3+ views | 114 | $28 | $91 |
| Hip X-ray, 2-3 views | 103 | $37 | $123 |
| X-ray of knee, 1-2 views | 95 | $27 | $90 |
| Knee X-ray, 3 views | 91 | $32 | $107 |
| Joint injection, major joint | 86 | $65 | $311 |
| Aspiration and/or injection of fluid from medium joint using ultrasound guidance | 82 | $77 | $315 |
| Injection of trigger points, 1-2 muscles | 79 | $34 | $172 |
| Aspiration and/or injection of fluid from small joint using ultrasound guidance | 78 | $66 | $277 |
| Injection of anesthetic agent and/or steroid into suprascapular shoulder nerve | 75 | $41 | $439 |
| Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve) | 61 | $130 | $443 |
| Injection of additional new drug or substance into vein | 61 | $12 | $62 |
| X-ray of upper spine, 4-5 views | 44 | $43 | $139 |
| X-ray of both knees while standing | 43 | $32 | $106 |
| Administration of chemotherapy into vein, each additional hour | 38 | $23 | $104 |
| Injection, diphenhydramine hcl, up to 50 mg | 32 | $1 | $3 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 32 | $406 | $3,048 |
| X-ray of middle spine, 2 views | 29 | $26 | $86 |
| Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | 28 | $38 | $140 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 26 | $57 | $334 |
| X-ray of both hips, 3-4 views | 26 | $43 | $145 |
| Injection of carpal tunnel | 23 | $74 | $297 |
| X-ray of upper spine, 2-3 views | 22 | $31 | $104 |
| X-ray of elbow, 2 views | 21 | $23 | $77 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 21 | $4 | $17 |
| Injection of anesthetic agent and/or steroid into rib nerve | 19 | $86 | $518 |
| Office visit, established patient, complex (40-54 min) | 17 | $145 | $474 |
| X-ray of knee, 4 or more views | 16 | $38 | $121 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $19 | $66 |
| Injection of anesthetic agent and/or steroid into multiple rib nerves for regional nerve block | 15 | $28 | $770 |
| X-ray of ribs on side of body, minimum of 3 views | 11 | $31 | $111 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kapelow is a mixed practice specialist, with above-average Medicare volume (top 11% in FL), with low-engagement industry engagement.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kapelow experienced with certolizumab injection (cimzia)?
Does Dr. Kapelow receive payments from pharmaceutical companies?
How do Dr. Kapelow's costs compare to other rheumatologists in Delray Beach?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology